» Articles » PMID: 36504613

Incidence of Bloodstream Infections in Patients with COVID-19: a Retrospective Cohort Study of Risk Factors and Outcomes

Overview
Journal Germs
Date 2022 Dec 12
PMID 36504613
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Prior evidence found that bloodstream infections (BSIs) are common in viral respiratory infections and can lead to heightened morbidity and mortality. We described the incidence, risk factors, and outcomes of BSIs in patients with COVID-19.

Methods: This was a single-center retrospective cohort study of adults consecutively admitted from March to June 2020 for COVID-19 with BSIs. Data were collected by electronic medical record review. BSIs were defined as positive blood cultures (BCs) with a known pathogen in one or more BCs or the same commensal organism in two or more BCs.

Results: We evaluated 290 patients with BCs done; 39 (13.4%) had a positive result. In univariable analysis, male sex, black/African American race, admission from a facility, hemiplegia, altered mental status, and a higher Charlson Comorbidity Index were positively associated with positive BCs, whereas obesity and systolic blood pressure (SBP) were negatively associated. Patients with positive BCs were more likely to have severe COVID-19, be admitted to the intensive care unit (ICU), require mechanical ventilation, have septic shock, and higher mortality. In multivariable logistic regression, factors that were independent predictors of positive BCs were male sex (OR=2.8, p=0.030), hypoalbuminemia (OR=3.3, p=0.013), ICU admission (OR=5.3, p<0.001), SBP<100 mmHg (OR=3.7, p=0.021) and having a procedure (OR=10.5, p=0.019). Patients with an abnormal chest X-ray on admission were less likely to have positive BCs (OR=0.3, p=0.007).

Conclusions: We found that male sex, abnormal chest X-ray, low SBP, and hypoalbuminemia upon hospital admission, admission to ICU, and having a procedure during hospitalization were independent predictors of BSIs in patients with COVID-19.

Citing Articles

Vitamin D and COVID-19: comparative analysis with other respiratory infections and impact of comorbidities.

Constantin L, Ungurianu A, Tarcomnicu I, Balulescu E, Margina D Germs. 2025; 14(3):232-245.

PMID: 39776957 PMC: 11703589. DOI: 10.18683/germs.2024.1435.


Examining the influence of Covid-19 restrictions, a nurse strike, and SARS-CoV-2 coinfection on bacteremia mortality: A Danish population-based cohort study (2019-2022).

Jansaker F, Holm M, Knudsen J, Boel J Heliyon. 2024; 10(13):e33696.

PMID: 39040231 PMC: 11261871. DOI: 10.1016/j.heliyon.2024.e33696.


Corticosteroid Dosing Level, Incidence and Profile of Bacterial Blood Stream Infections in Hospitalized COVID-19 Patients.

Papic I, Bistrovic P, Cikara T, Busic N, Keres T, Hadziabdic M Viruses. 2024; 16(1).

PMID: 38257786 PMC: 10820464. DOI: 10.3390/v16010086.

References
1.
Aziz M, Fatima R, Lee-Smith W, Assaly R . The association of low serum albumin level with severe COVID-19: a systematic review and meta-analysis. Crit Care. 2020; 24(1):255. PMC: 7249975. DOI: 10.1186/s13054-020-02995-3. View

2.
Wiersinga W, Rhodes A, Cheng A, Peacock S, Prescott H . Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review. JAMA. 2020; 324(8):782-793. DOI: 10.1001/jama.2020.12839. View

3.
Suleyman G, Fadel R, Malette K, Hammond C, Abdulla H, Entz A . Clinical Characteristics and Morbidity Associated With Coronavirus Disease 2019 in a Series of Patients in Metropolitan Detroit. JAMA Netw Open. 2020; 3(6):e2012270. PMC: 7298606. DOI: 10.1001/jamanetworkopen.2020.12270. View

4.
Giacobbe D, Battaglini D, Ball L, Brunetti I, Bruzzone B, Codda G . Bloodstream infections in critically ill patients with COVID-19. Eur J Clin Invest. 2020; 50(10):e13319. PMC: 7323143. DOI: 10.1111/eci.13319. View

5.
Lippi G, Plebani M . Laboratory abnormalities in patients with COVID-2019 infection. Clin Chem Lab Med. 2020; 58(7):1131-1134. DOI: 10.1515/cclm-2020-0198. View